Mastercard Foundation Scholars Program opens doors for African students in UK
The Mastercard Foundation Scholars Program at the University of Oxford, in collaboration with the Africa Oxford Initiative (AfOx), offers a ...
The Mastercard Foundation Scholars Program at the University of Oxford, in collaboration with the Africa Oxford Initiative (AfOx), offers a ...
The Weidenfeld-Hoffmann Scholarships and Leadership Programme offers an opportunity for graduates from developing and emerging economies to pursue fully funded ...
The World cybercrime index identifies the globe’s major cybercrime hotspots by ranking the most significant sources of cybercrime at a ...
South Africa has suspended the roll-out of Oxford/AstraZeneca COVID-19 vaccine over limited protection against new coronavirus variant.
Fossil fuel is expected to dominate Africa’s energy mix by the end of the decade.
AstraZeneca has said that its vaccine being developed in collaboration with the University of Oxford could be 90% effective.
The experimental vaccine being developed by AstraZeneca Plc produced a robust immune response in older adults and the elderly.
After concerns on safety triggered a pause, AstraZeneca has resumed clinical trial of it's vaccine.
The human trials of the Oxford vaccine are expected to be through in September.